Identification | More | [Name]
6-Nitroindoline | [CAS]
19727-83-4 | [Synonyms]
2,3-DIHYDRO-6-NITRO-(1H)-INDOLE 6-NITRO-2,3-DIHYDRO-1H-INDOLE 6-NITRO-2,3-DIHYDRO-1H-INDOLE HYDROCHLORIDE 6-NITRO-2,3-DIHYDROINDOLE 6-NITROINDOLINE 6-nitro-indolin 6-Nitroindzole 6-NITROINDOLINE, 98+% 2,3-DIHYDRO-6-NITROINDOLE 1H-Indole, 2,3-dihydro-6-nitro- | [EINECS(EC#)]
243-257-6 | [Molecular Formula]
C8H8N2O2 | [MDL Number]
MFCD00005710 | [Molecular Weight]
164.16 | [MOL File]
19727-83-4.mol |
Chemical Properties | Back Directory | [Appearance]
orange crystalline powder or red crystals | [Melting point ]
67-69 °C (lit.) | [Boiling point ]
291.62°C (rough estimate) | [density ]
1.2739 (rough estimate) | [refractive index ]
1.6000 (estimate) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [form ]
Crystalline Powder or Crystals | [pka]
3.39±0.20(Predicted) | [color ]
Orange or red | [BRN ]
156434 | [CAS DataBase Reference]
19727-83-4(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
3
| [RTECS ]
NM1950000
| [Hazard Note ]
Irritant | [HS Code ]
29339900 |
Hazard Information | Back Directory | [Chemical Properties]
orange crystalline powder or red crystals | [Uses]
• ;Reactant for preparation of 2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin analogs as novel MT2-selective melatonin receptor antagonists1• ;Reactant for synthesis of isoindigo and azaisoindigo glycosides as anticancer agents2• ;Reactant for preparation of arylfurancarboxamides with Nav1.8 voltage-gated Na channel blocking/analgesic activities3• ;Reactant for preparation of bicyclic benzamides as 5-HT1 receptor agonists4• ;Reactant for preparation of antiarrhythmic benzopyrans5• ;Reactant for preparation of 5-HT2C/2B receptor antagonists6 | [Uses]
- Reactant for preparation of 2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin analogs as novel MT2-selective melatonin receptor antagonists
- Reactant for synthesis of isoindigo and azaisoindigo glycosides as anticancer agents
- Reactant for preparation of arylfurancarboxamides with Nav1.8 voltage-gated Na channel blocking/analgesic activities
- Reactant for preparation of bicyclic benzamides as 5-HT1 receptor agonists
- Reactant for preparation of antiarrhythmic benzopyrans
- Reactant for preparation of 5-HT2C/2B receptor antagonists
|
|
|